CDC advisory panel recommends seniors ‘may’ get RSV vaccine
A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations opted Wednesday not to recommend that all seniors get a vaccine to protect against RSV.
Instead, the Advisory Committee on Immunization Practices said that anyone 60 and older should be able to get one of the new vaccines — being brought to market by GSK and Pfizer — if they and their physicians think it would be worthwhile.
Read Original Article: CDC advisory panel recommends seniors ‘may’ get RSV vaccine »
